4.8 Review

Bioengineering strategies to accelerate stem cell therapeutics

期刊

NATURE
卷 557, 期 7705, 页码 335-342

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41586-018-0089-z

关键词

-

资金

  1. Stanford ChEM-H Interdisciplinary Postdoctoral Training Program in Quantitative Mechanobiology
  2. National Institutes of Health (NIH) [U19 AI116484, R21 HL13804201]
  3. National Science Foundation [DMR 1508006]
  4. California Institute for Regenerative Medicine (CIRM) [RT3-07948]
  5. NIH [R01 AG020961, R01 AR063963, R01 NS089533, R01 HG00967401]
  6. CIRM [DISC1-10036]
  7. American Heart Association [17CSA33590101]
  8. Baxter Foundation
  9. Li Ka Shing Foundation
  10. Division Of Materials Research
  11. Direct For Mathematical & Physical Scien [1508006] Funding Source: National Science Foundation

向作者/读者索取更多资源

Although only a few stem cell-based therapies are currently available to patients, stem cells hold tremendous regenerative potential, and several exciting clinical applications are on the horizon. Biomaterials with tuneable mechanical and biochemical properties can preserve stem cell function in culture, enhance survival of transplanted cells and guide tissue regeneration. Rapid progress with three-dimensional hydrogel culture platforms provides the opportunity to grow patient-specific organoids, and has led to the discovery of drugs that stimulate endogenous tissue-specific stem cells and enabled screens for drugs to treat disease. Therefore, bioengineering technologies are poised to overcome current bottlenecks and revolutionize the field of regenerative medicine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据